(Q28191806)

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Antithrombotic therapy in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Medical treatment for stroke prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Preventing stroke in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Service provision and use of anticoagulants in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Treatment of atrial fibrillation in a district general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Survey of use of anticoagulation in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Temporal trends in the use of anticoagulants among older adults with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Do anticoagulation clinics treat patients more effectively than physicians?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Complication rates for a telephone-based anticoagulation service.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Risk factors for intracranial hemorrhage in outpatients taking warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021

Risk assessment and anticoagulation for primary stroke prevention in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980134-X

7 January 2021